Solid Biosciences Inc. logo

Solid Biosciences Inc.

NASDAQ:SLDB

Overview | Financials
Company Name Solid Biosciences Inc.
Symbol SLDB
Currency USD
Price 5.66
Market Cap 218,448,832
Dividend Yield 0%
52-week-range 2 - 15.05
Industry Biotechnology
Sector Healthcare
CEO Mr. Alexander G. Cumbo
Website https://www.solidbio.com

An error occurred while fetching data.

About Solid Biosciences Inc.

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate

Related Stocks

ReWalk Robotics Ltd. logo

ReWalk Robotics Ltd.

RWLK

1.05 USD

Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp.

MDNA

0.157 USD

Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc.

HEPA

0.634 USD

Pro-Dex, Inc. logo

Pro-Dex, Inc.

PDEX

40.63 USD

MEI Pharma, Inc. logo

MEI Pharma, Inc.

MEIP

3.06 USD

Financials

Numbers are in millions USD

Numbers are in millions USD